(AASLD) The Liver Meeting® 2025
Nov 11, 2025 at 11:45 AM EST
Abstract Title: A Phase 2, Multicenter, Randomized, Placebo-Controlled Trial of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis
Session: Late-Breaking Abstracts Parallel Session 3 (publication number 5001)
Speaker: Dr. Mazen Noureddin, Professor of Medicine at the Houston Methodist Hospital and Co-Chairman of the Board for Summit and Pinnacle Clinical Research
Supporting Materials
Location
Washington, D.C.
